Solventum rises after $4.1 billion sale of purification and filtration unit
** Medical device maker Solventum's SOLV.N shares rise 1.8% to $77.67 premarket ** Co says Thermo Fisher TMO.N will buy its purification and filtration business for about $4.1 billion in cash ** The transaction is expected to be completed by the end of 2025 ** Up to last close, SOLV down 4.7% since close on March 26, 2024, after spin off from 3M (Reporting by Puyaan Singh) ((Puyaan.Singh@thomsonreuters.com;))
Recent news on Solventum
See all newsSolventum Corporation reports results for the quarter ended June 30 - Earnings Summary
Solventum to hive off healthcare software business, raises profit forecast
Solventum Q2 sales, adjusted EPS beat estimates; FY outlook lifted
Solventum Corp expected to post earnings of $1.91 a share - Earnings Preview
Solventum forecasts annual profit at higher end on wound care demand